Generation Bio Co. financial data

Symbol
GBIO on Nasdaq
Location
301 Binney Street, Cambridge, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 667 % -14.3%
Debt-to-equity 171 % +86.3%
Return On Equity -91.1 % +1.93%
Return On Assets -33.7 % +30.6%
Operating Margin -381 % +70.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 6.74M shares -89.9%
Common Stock, Shares, Outstanding 6.73M shares -89.9%
Entity Public Float 155M USD -48.2%
Common Stock, Value, Issued 1K USD -85.7%
Weighted Average Number of Shares Outstanding, Basic 6.7M shares +0.76%
Weighted Average Number of Shares Outstanding, Diluted 6.7M shares +0.76%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 21.2M USD +61.2%
Research and Development Expense 61.4M USD -23.7%
General and Administrative Expense 34.3M USD -23.6%
Operating Income (Loss) -81M USD +52.6%
Nonoperating Income (Expense) 10.7M USD -10.3%
Net Income (Loss) Attributable to Parent -72.4M USD +54.3%
Earnings Per Share, Basic -1 USD/shares +78.1%
Earnings Per Share, Diluted -1 USD/shares +78.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 49.1M USD +72.3%
Marketable Securities, Current 92.3M USD -51%
Accounts Receivable, after Allowance for Credit Loss, Current 256K USD -80.9%
Other Assets, Current 160K USD -44.8%
Assets, Current 146M USD -34.8%
Property, Plant and Equipment, Net 13.3M USD -22.2%
Operating Lease, Right-of-Use Asset 18.4M USD -16.7%
Other Assets, Noncurrent 67K USD -66.5%
Assets 179M USD -32.4%
Accounts Payable, Current 2.23M USD +16.9%
Employee-related Liabilities, Current 2.85M USD -26.6%
Contract with Customer, Liability, Current 5.68M USD
Liabilities, Current 19.4M USD -35.7%
Contract with Customer, Liability, Noncurrent 55.1M USD
Operating Lease, Liability, Noncurrent 75.6M USD -11.4%
Other Liabilities, Noncurrent 0 USD
Liabilities 125M USD -16.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax 4K USD
Retained Earnings (Accumulated Deficit) -739M USD -10.9%
Stockholders' Equity Attributable to Parent 54.1M USD -53.1%
Liabilities and Equity 179M USD -32.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.4M USD +10.5%
Net Cash Provided by (Used in) Financing Activities -125K USD -100%
Net Cash Provided by (Used in) Investing Activities 2.96M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 6.73M shares -89.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 51.2M USD +67.2%
Deferred Tax Assets, Valuation Allowance 214M USD +22.1%
Operating Lease, Liability 62M USD
Payments to Acquire Property, Plant, and Equipment 246K USD -87.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -72.1M USD +54.5%
Lessee, Operating Lease, Liability, to be Paid 137M USD +31.1%
Property, Plant and Equipment, Gross 38.2M USD -16%
Operating Lease, Liability, Current 9.75M USD +13%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.6M USD +2.83%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.2M USD +13.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 38.9M USD -13.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 16.1M USD +2.92%
Deferred Tax Assets, Operating Loss Carryforwards 105M USD +8.37%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.6M USD +2.83%
Operating Lease, Payments 1.9M USD -38.7%
Additional Paid in Capital 793M USD +1.39%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 4.66M USD -11.2%
Deferred Tax Assets, Net of Valuation Allowance 222M USD +12.4%
Share-based Payment Arrangement, Expense 10.6M USD -46.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%